Objective To evaluate if postnatal treatment with betamethasone in extremely preterm infants was associated with neurodevelopmental impairment (NDI) at 6.5 years of age. Design Prospective cohort ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback